Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in Ghanaians. 1985

N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith

The ability to oxidize sparteine to form 2- and 5-dehydrosparteine was studied in 154 healthy Ghanaians. Although the urinary metabolic sparteine/dehydrosparteines ratio varied widely (from 0.14 to 12.5), in contrast to observations in several Caucasian population groups the ratios were not bimodally distributed and no phenotypically poor oxidizers of sparteine were found. The ability of these same subjects to oxidize debrisoquin and phenformin was also studied in 141 and 143 subjects. Of the 141 subjects dosed with debrisoquin, 10 proved to be poor oxidizers, and of the 143 subjects dosed with phenformin, 11 were poor oxidizers. All the poor oxidizers of debrisoquin were also poor oxidizers of phenformin. The 10 confirmed poor metabolizers of debrisoquin, who had debrisoquin metabolic ratios ranging from 14.4 to 52.0, had sparteine metabolic ratios ranging only from 0.15 to 12.5. Whereas Caucasian poor metabolizers of sparteine excrete less than 2.0% of a dose as dehydrosparteines, the mean excretion of dehydrosparteines in our 10 subjects was 20.6% +/- 13.2%. The overall rank correlation between the sparteine and debrisoquin metabolic ratios was low (rs = 0.47), while the coefficient of determination for linear regression (r2) was only 0.17. Our data show that the ability of Ghanaians to oxidize sparteine is largely independent of their capacity for debrisoquin oxidation and is indicative of a major interethnic difference in the genetic control of these reactions.

UI MeSH Term Description Entries
D007546 Isoquinolines A group of compounds with the heterocyclic ring structure of benzo(c)pyridine. The ring structure is characteristic of the group of opium alkaloids such as papaverine. (From Stedman, 25th ed)
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010629 Phenformin A biguanide hypoglycemic agent with actions and uses similar to those of METFORMIN. Although it is generally considered to be associated with an unacceptably high incidence of lactic acidosis, often fatal, it is still available in some countries. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290) Fenformin,Phenylethylbiguanide
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003647 Debrisoquin An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism. Debrisoquine,Tendor
D005260 Female Females
D005869 Ghana A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra. Gold Coast,Republic of Ghana
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
January 1986, Progress in clinical and biological research,
N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
November 1979, Clinical pharmacology and therapeutics,
N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
January 1991, Farmakologiia i toksikologiia,
N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
September 1991, Clinical pharmacology and therapeutics,
N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
June 1991, Clinical pharmacology and therapeutics,
N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
May 1989, Clinical pharmacology and therapeutics,
N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
November 1985, Acta pharmacologica et toxicologica,
N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
July 1988, Clinical pharmacology and therapeutics,
N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
January 1986, Progress in clinical and biological research,
N M Woolhouse, and M Eichelbaum, and N S Oates, and J R Idle, and R L Smith
April 1992, Pharmacogenetics,
Copied contents to your clipboard!